Ty Humes
Ty Humes, Trustee
Term of Office: Provisional Appointment (April 22, 2021 - June 9, 2021)
Ty Humes is the Senior Executive who Heads up Global Business Development for the international firm, Wondros. He is an astute, versatile and proficient senior executive with extensive C-Level experience in managing organizations, sales, marketing, organizational growth and revenue generation. Prior to Wondros, he was the Vice President of Corporate Development for Theragene Pharmaceuticals, Inc. In the role, he led the management of all global sales, marketing, corporate development, PR and investment banking activities and staff for both the public and private company divisions and its oncology and biotech initiatives between US and China.
In addition, Mr. Humes has served as the Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Investment Officer for both public and private companies over the past thirty plus years. He has also been involved with Initial Public Offerings, Mergers & Acquisitions, Private Placement Memorandums and the sale and purchase of six firms. Furthermore, he currently serves on three Boards of Directors and serves as Chairman on two of the Boards. This is inclusive of nonprofit and for profit companies. Mr. Humes is widely regarded as a Paradigm Pioneer and Thought Leader.
